Kerala’s medicine shortage dispute intensified in the Assembly after Health Minister K Muraleedharan acknowledged difficulties in the availability of 26 medicines, while rejecting opposition claims that the state’s government healthcare system was in critical condition.
The exchange took place during a debate on the medicine stock situation in government hospitals. The opposition had sought leave for an adjournment motion alleging shortages and wider problems in the public healthcare system. CPM MLA K V Sumesh moved the motion and argued that the state’s healthcare system was facing serious difficulties.
Muraleedharan dismissed the allegations as exaggerated but accepted that medicine availability had been affected. He said steps had been taken to address the problem urgently, without indicating in the reported Assembly exchange when supplies of all the affected medicines would be restored.
The minister attributed part of the procurement disruption to events in March, when purchase orders were not issued because of the Model Code of Conduct. In a government hospital system, such interruptions can affect the timing of replenishment even when the underlying requirement for medicines remains unchanged. The Assembly debate placed the procurement process, rather than only hospital-level stock management, at the centre of the dispute.
Muraleedharan also blamed the previous LDF government for accumulating substantial arrears payable to pharmaceutical companies. According to the minister, the unpaid dues affected the procurement process and contributed to the difficulties in securing medicines. The opposition, however, accused the minister of treating the reported shortages lightly, turning the discussion into a wider political confrontation over the management of public healthcare.
The minister’s remarks also included a pointed political reference. Responding to the allegations, he said that a medicine for the “disease of losing power” was the only one unavailable. The comment triggered criticism from the opposition, which argued that reported shortages in government hospitals should not be treated as a political joke.
The dispute highlights how medicine availability in public hospitals depends on more than clinical demand. Purchase orders, payment arrears, procurement calendars and administrative decisions can all influence whether hospitals are able to maintain regular stocks. The Assembly exchange, however, did not establish the extent of shortages at individual hospitals, the number of patients affected or whether all 26 medicines were unavailable statewide.
The immediate administrative question is whether the corrective measures cited by the health minister will restore supplies across the affected facilities. The minister said the government was taking urgent steps to resolve the difficulties, while maintaining that the opposition had overstated the seriousness of the situation.
